Alveolar macrophages from COPD patients (n = 8) and S (n = 8) were treated with the Nrf2 activators CDDO, GSK7, C4X_6665, Sulforaphane and MMF. The gene discussed is NFE2L2; the disease is chronic obstructive pulmonary disease.